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Chronic stress impairs auditory attention in rats and monoamines regulate
neurotransmission in the primary auditory cortex (A1), a brain area that modulates
auditory attention. In this context, we hypothesized that norepinephrine (NE) levels
in A1 correlate with the auditory attention performance of chronically stressed rats.
The first objective of this research was to evaluate whether chronic stress affects
monoamines levels in A1. Male Sprague–Dawley rats were subjected to chronic
stress (restraint stress) and monoamines levels were measured by high performance
liquid chromatographer (HPLC)-electrochemical detection. Chronically stressed rats
had lower levels of NE in A1 than did controls, while chronic stress did not affect
serotonin (5-HT) and dopamine (DA) levels. The second aim was to determine the
effects of reboxetine (a selective inhibitor of NE reuptake) on auditory attention and
NE levels in A1. Rats were trained to discriminate between two tones of different
frequencies in a two-alternative choice task (2-ACT), a behavioral paradigm to
study auditory attention in rats. Trained animals that reached a performance of
≥80% correct trials in the 2-ACT were randomly assigned to control and stress
experimental groups. To analyze the effects of chronic stress on the auditory task,
trained rats of both groups were subjected to 50 2-ACT trials 1 day before and
1 day after of the chronic stress period. A difference score (DS) was determined
by subtracting the number of correct trials after the chronic stress protocol from
those before. An unexpected result was that vehicle-treated control rats and vehicle-
treated chronically stressed rats had similar performances in the attentional task,
suggesting that repeated injections with vehicle were stressful for control animals
and deteriorated their auditory attention. In this regard, both auditory attention and
Abbreviations: µL, microlitres; 2-ACT, two-alternative choice task; 5-HIAA, 5-Hydroxyindoleacetic acid; 5-HT, serotonin;
A1, primary auditory cortex; CH3CN, acetonitrile; cm, centimeters; CRF, corticotropin-releasing factor; dB, decibel;
DS,difference score;DS-CT,difference scoreof correct trials; EDTA,Ethylenediaminetetraacetic acid; g, grams;GABA,gamma-
Aminobutyric acid; h, hour; HPA, hypothalamus-pituitary-adrenal; HPLC, high performance liquid chromatographer;
IP, Internet Protocol address; IPSCs, inhibitory postsynaptic currents; kg, kilograms; kHz, kilohertz; LC, locus coeruleus;
m, meter; M, molar; mg, milligrams; min, minutes; mL, milliliters; mM, millimolar; mV, millivolts; µL, microlitres;
N, normal; nA, nanoampere; NaH2PO4, Sodiumphosphatemonobasic; NE, norepinephrine; ng, nanograms; nm, nanometers;
pg, picograms; s, seconds.
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NE levels in A1 were higher in chronically stressed rats treated with reboxetine than in
vehicle-treated animals. These results indicate that NE has a key role in A1 and attention
of stressed rats during tone discrimination.
Keywords: stress, norepinephrine, auditory cortex, attention
INTRODUCTION
Stress is a non-specific biological response of an organism
to environment demands that affect their homeostasis.
Consequently, stress allows them to restore homeostasis and
adapt to environmental threats (Selye, 1936, 1956). Stressors are
imminent or perceived challenges to homeostasis that activate
the hypothalamus-pituitary-adrenal (HPA) axis, leading to the
release of the steroids hormones from adrenal glands (cortisol
in humans and corticosterone in rodents; Calabrese et al., 2007;
Hennebelle et al., 2014).
Stress can be positive (eustress) when the stressors are mild,
brief and controllable (Tafet and Bernardini, 2003). When the
stressors are too intense and persistent (chronic stress), stress
responsesmay becomemaladaptive, affecting brain structure and
function (Tafet and Bernardini, 2003). In this sense, we have
shown that the rat auditory system is sensitive to the effects of
chronic stress (Dagnino-Subiabre, 2013). For instance, chronic
stress and chronic corticosterone treatment induce dendritic
atrophy in the central auditory pathways, such as the pyramidal
neurons from primary auditory cortex (A1; Dagnino-Subiabre
et al., 2005, 2009, 2012; Bose et al., 2010). These morphological
alterations correlate with lower inhibitory synaptic efficacy in
A1 compared to controls not exposed to chronic stress, as
well as impairments in the auditory attention (Pérez et al.,
2013).
In agreement with evidence obtained in rats, psychosocial
stress and stress-related disorders (e.g., depression) in humans
produce alterations in cognitive functions, such as attention
(Gotlib and McCann, 1984; Mialet et al., 1996; Ottowitz et al.,
2002; Kähkönen et al., 2007; Simoens et al., 2007; Kimble
et al., 2010). Moreover, electroencephalographic recordings
demonstrate that psychosocial stress in humans decreases general
sound processing (mismatch negativity and N1/P2; Simoens
et al., 2007).
Attention is a cognitive function that allows animals to select
relevant stimulus in the environment and ignore irrelevant
stimuli (Raz, 2004). The behavioral paradigm two-alternative
choice task (2-ACT) is used to study auditory attention in rats
(Otazu et al., 2009; Jaramillo and Zador, 2011; Znamenskiy and
Zador, 2013; Xiong et al., 2015). In this paradigm, auditory
attention is associated with increases in neural activity in A1,
which is required to process information of attention (Hromádka
and Zador, 2007; Xiong et al., 2015). As well, behavioral
and electrophysiological studies have shown a significant
positive association between the animal’s performances in the
attentional task and increased activity in A1 (Xiong et al.,
2015).
On the other hand, norepinephrine (NE) is released from
the locus coeruleus nucleus (LC, located at the brainstem)
during focused attention to relevant stimuli (Aston-Jones and
Waterhouse, 2016). LC activity is modulated by eustress during
attention tasks. For instance, eustress activates the corticotropin-
releasing factor (CRF) neurons located in the LC (Merchenthaler
et al., 1982; Palkovits et al., 1985) and consequently NE
is released to brain areas involved in auditory attention,
for example the auditory cortex (Salgado et al., 2012) and
frontal cortex (Aston-Jones et al., 2000). Thus, NE-LC system
enhances attention during the stress responses (Carli et al.,
1983; De Martino et al., 2008). The A1 activity is strongly
modulated by NE (Manunta and Edeline, 2000; Gaucher and
Edeline, 2015), specifically pyramidal neurons located at layers
II/III (Salgado et al., 2012). This neurotransmitter is released
in A1 by projections from the LC. As a result, α2 or β
adrenoceptors are activated, enhancing GABAergic synaptic
transmission, while stimulation α1-adrenoceptors suppress
inhibitory postsynaptic currents (IPSCs) in the A1 (Salgado et al.,
2011a,b). Rats treated with an α2-adrenoceptor-antagonist drug
show higher levels of attention than controls (Brown et al.,
2012).
Together, these studies show that there is a relationship
between LC-NE system, GABAergic transmission in A1 and
auditory attention, which raise the question of whether chronic
stress affects monoamine levels in the A1. Thus, the objectives of
this study were to test whether repeated restraint stress affects:
(1) NE, 5-HT and dopamine (DA) levels in the auditory cortex;
and (2) the behavioral performance in an auditory attention task.
We found that chronically stressed rats had lower levels of NE
in A1 than controls, while 5-HT and DA levels were similar.
We evaluated the effects of reboxetine on NE levels and on a
performance in an auditory attention task. The main results were
that control and chronically stressed rats treated with reboxetine
had similar NE levels in the auditory cortex and comparable
performance in the auditory attention task.
MATERIALS AND METHODS
Ethics Statement
All procedures related to animal maintenance and
experimentation were approved by the Institutional Animal
Ethics Committee of the Faculty of Sciences Universidad de
Valparaíso (Chile) and were in strict accordance with animal
care standards outlined in National Institutes of Health (USA)
guidelines. Efforts weremade tominimize the number of animals
used and their suffering. The antidepressant drug reboxetine at
doses of 0.65 mg/kg (Pfizer, Pharmacia and Upjohn) or saline
(vehicle, 0.9% NaCl) were intraperitoneal injected one time daily
at 9:00–10:00 am for 21 days (Scheme 1B; Ampuero et al., 2015).
Animals and Restraint Stress Protocol
Hundred sixty male Sprague–Dawley rats (control, n = 80,
stress, n = 80) were used in all experiments of this study.
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SCHEME 1 | Structure of the basic two-alternative choice task (2-ACT) and schematic drawing of the experimental design. (A) 2-ACT is an auditory
attention task; the trial initiates when the rat pokes its nose into the center port (left), which triggers the computer to randomly present one of two types of auditory
stimuli, a high (15 kHz) or low (1 kHz) frequency tone (right). Rats were trained to respond with a left poke for high tones and a right poke for low tones; correct trials
were rewarded with water. (B) The arrow represents the postnatal days of the animals (PND). After weaning, rats were trained in the 2-ACT for 20 days. Afterward,
animals were randomly assigned to two experimental groups: control and stress. Trained rats were used in the Experiment 1 (Exp. 1) to determine monoamine levels
in A1 1 day after chronic stress ended, and in Experiment 2 (Exp. 2) to analyze the stress markers. Experiment 3 (Exp. 3) analyzed the effects of chronic stress on
auditory attention. Trained rats that were subjected to 50 2-ACT trials 1 day before and after the restraint stress protocol. A difference score (DS) was then
determined by subtracting the correct trials after chronic stress (DS-CT) from those before. Experiment 4 (Exp. 4) analyzed NE levels in rats treated with reboxetine.
Control animals, which were littermates of the stress-treated
animals, were housed in separate rooms and cages, and not
subjected to chronic stress. Restraint-stressed rats were placed
in a plastic rat restrainer (6 cm diameter × 12 cm long and
later 6 cm diameter × 20 cm long as the rats grew) in their
home cages for 6 h daily, beginning at 10:00 h to 16:00 h
for 21 consecutive days. Restraint occurred during the light
phase of the light/night cycle. Animals were housed in groups
of three per cage under a 12/12 light/dark cycle (lights on at
08:00 h), with ad libitum access to food (rat chow, Championr,
Santiago, Chile) and water in a temperature and humidity
controlled room (20 ± 1◦C, 55 ± 5%, respectively). Rats were
weighed every day on a digital scale (Model WLC2/A1, Radwag,
Poland).
After weaning (PND 23), 40 rats were trained for 3 weeks in a
2-ACT task, a behavioral task used to evaluate auditory attention
in rodents (Scheme 1A). Trained rats were randomly distributed
to two experimental groups: control, n = 20 and stress, n = 20.
TWO-ALTERNATIVE CHOICE TASK
Stimuli Delivery and Apparatus
To determine auditory attention, the animals were trained to
discriminate tones in a 2-ACT paradigm (Jaramillo and Zador,
2011; Xiong et al., 2015). Four modular rat operant chambers
and accessories (LE1005, LE10022, LE100575, LE100560, Panlab
S.L., Barcelona, Spain) were used in the attention task, each
within a 67 cm3 × 67 cm3 × 67 cm3 sound-attenuating cubicle
lined with 7.5 cm acoustic foam (Vroka S.A., Santiago, Chile).
The operant chamber was illuminated to 200 lux (measured
by a digital lux meter, Model # LX-1010B, Weafo Instrument
Co., Shanghai, China) and the background noise level was
30 dB SPL. During training, the auditory stimuli were delivered
through a speaker calibrated with a precision sound level meter
(Model # 1100, Quest Technologies, Oconomowoc, WI, USA)
to generate 70 dB SPL in the frequency range of 1–15 kHz
at the position of the subject. The duration of the auditory
stimuli was 0.1 s. The speaker was mounted in front of the three
nose-poke, each connected with a liquid dispenser (Figure 1A).
Operant modules were regulated by Packwin V1.2 software
(Panlab S.L., Barcelona, Spain). All experiments were recorded
with an IP camera (VIVOTEK, Sunnyvale, CA, USA) fixed above
each operant chamber. Videos were acquired by Nuuo software
(Nuuo, Taipei, Taiwan).
Behavioral Task
Three days after weaning, male Sprague–Dawley rats (23 days old
at the start of the experiment) were trained in the behavioral
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FIGURE 1 | Effect of chronic stress on monoamine levels in the auditory cortex. (A) Chronic stress reduced norepinephrine (NE) concentration in the auditory
cortex while it did not affect 5-HT (B) and dopamine (DA) (C) levels, and their metabolites 5-HIAA and dopac. Chronically stressed rats had comparable 5-HIAA/5-HT
and dopac/DA ratios to those of controls (D). ∗∗p < 0.01.
2-ACT paradigm. Animals were water deprived over night
under a protocol approved by the Institutional Animal Ethics
Committee of the Faculty of Sciences, Universidad de Valparaíso,
Chile. Afterward, the rat initiated a trial by inserting its nose
into the central nose-poke of a three-port operant chamber
(Scheme 1A), which triggered the computer to randomly present
two types of acoustic stimuli: (1) a low frequency tone at 1 kHz;
and (2) a high frequency tone at 15 kHz. The rats were trained
to respond with right pokes for low frequency tones and left
pokes for high-frequency tones. Correct trials were rewarded
with water (Scheme 1A). All operant chambers were thoroughly
cleaned with a 5% ethanol solution after each session. The control
and chronically stressed groups were evaluated at the same
time.
The 2-ACT training has three steps; in each of which
it is possible to independently analyze learning, memory
consolidation and auditory attention (Scheme 1B). In the first
week of training, rats learned to respond with right pokes for
low tones and left pokes for high tones (learning period). In the
second week, rats were trained in 50 2-ACT trials until reaching
70% correct trials. At the end of this week the rats’ memory
related to 2-ACT was consolidated (memory consolidation
period). Beginning of the third week, the rats recalled the task and
improved their auditory attention increasing correct responses
to over 80% of trials (auditory attention period; Pérez et al.,
2013).
Experimental Design
Scheme 1B shows a schematic drawing of the experimental
design used in this study. Table 1 shows the number of rats used
in each experiment. Experiment 1 analyzed the effect of repeated
restraint stress on monoamine levels in A1 (control, n = 6, stress,
n = 6). Experiment 2 analyzed the effect of reboxetine on body
weight gain and locomotor activity of rats after the chronic stress
protocol ended (control: vehicle, n = 9, reboxetine, n = 9; stress:
vehicle, n = 9, reboxetine, n = 9). The stress levels after the
chronic stress period were also evaluated. The most conventional
method to determine if the animals are chronically stressed is
to measure plasma levels of the stress hormone corticosterone.
Animals were exposed to a new stressor (forced swim) and
corticosterone plasma levels were quantified before and after
acute swim exposure (Unstimulated, control: vehicle, n = 6,
reboxetine, n = 6; stress: vehicle, n = 6, reboxetine, n = 6. Acute
swim, control: vehicle, n = 6, reboxetine, n = 6; stress: vehicle,
n = 6, reboxetine, n = 6). In Experiment 3, we studied the effect
of reboxetine on auditory attention of chronically stressed rats.
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TABLE 1 | Number of rats used in each experiment.
Experiment Description Experimental group Total
1 Monoamine levels in Al Control Stress
n = 6 n = 6 n = 12
2 Stress markers Vehicle Reboxetine Vehicle Reboxetine
Body weight and locomotor activity n = 9 n = 9 n = 9 n = 9 n = 36
Corticosterone levels in unstimulated rats n = 6 n = 6 n = 6 n = 6 n = 24
Corticosterone levels after acute swim n = 6 n = 6 n = 6 n = 6 n = 24
3 Auditory attention n = 10 n = 10 n = 10 n = 10 n = 40
4 NE levels in Al n = 6 n = 6 n = 6 n = 6 n = 24
Total n = 160
After 3 weeks of training, rats that reached a correct performance
of over 80% in 50 trials were included in this experiment. The
animals were randomly assigned to two groups: control: vehicle,
n = 10, reboxetine, n = 10 and stress: vehicle, n = 10, reboxetine,
n = 10, and 1 day before and after of the chronic stress protocol,
the rats were subjected to 50 trials of 2-ACT (Scheme 1B).
Only in the Experiment 3 trained animals were used in the
2-ACT. Experiment 4 evaluated whether reboxetine affects the
NE levels in the auditory cortex of chronically stressed rats
(control: vehicle, n = 6, reboxetine, n = 6; stress: vehicle, n = 6,
reboxetine, n = 6).
EXPERIMENT 1
Monoamine Contents in the Auditory
Cortex
After completion of the chronic stress protocol each rat was
decapitated under deep anesthesia with isoflurane. The brain was
removed quickly and the auditory cortex was microdissected at
4◦C according toHébert et al. (1987) and Basura et al. (2008). The
tissue was collected in 400 µL of 0.2 N perchloric acid and then
homogenized in a glass-glass homogenizer. The homogenate was
centrifuged at 12,000 g for 15 min at 4◦C (Model Z233MK-2,
Hermle LaborTechnik GmbH, Germany) and the supernatant
was injected into a high performance liquid chromatographer
(HPLC) coupled to electrochemical detection, to measure NE,
5-HT and DA content. The contents of all monoamines were
expressed as picograms per milligram of tissue. Ten microliters
of each supernatant were injected into the HPLC system with the
following setting: a isocratic pump (Model PU-2080 Plus, Jasco
Co. Ltd., Tokyo, Japan), a UniJet microbore column (MF-8912,
BAS, West Lafayette, IN, USA) and an amperometric detector
(set at 650 mV, 0.5 nA; Model LC-4C, BAS, West Lafayette,
IN, USA). The mobile phase, containing 0.05 M NaH2PO4,
1.0 mM 1-octanesulfonic acid, 0.27 mM EDTA, 1.0% (v/v)
tetrahydrofuran and 4.0% (v/v) CH3CN (pH adjusted to 2.6)
was pumped at a flow rate of 100 µL/min. Neurotransmitter
levels were assessed by comparing the respective peak area and
elution time of the sample with a reference standard and the
quantification was performed using a calibration curve for each
neurotransmitter (Program ChromPass, Jasco Co. Ltd., Tokyo,
Japan). Under these experimental conditions, retention times
were 3.4 min for NE, 7.1 min for DA and 16.0 min for 5-HT.
Standards, EDTA and 1-octanesulfonic acid, were purchased
from Sigma-Aldrich, Inc. (St. Louis, MO, USA), and all other
reagents were of analytical grade. The detection limit for DA,
Dopac, 5-HT, 5-HIAA and NE was 0.1 pg/mg of tissue.
EXPERIMENT 2
Stress Markers
Body Weight Gain
To analyze the effects of the stress procedure, we measured the
percentage gain in body weight at the beginning and end of
the experimental period (net change in weight after experiment
×100/weight at the beginning of the experiment).
Determination of Plasma Corticosterone
We used a separate set of rats to determine the corticosterone
concentration in plasma to avoid the stress of blood collection
affecting behavioral or HPLC experiments. A set of rats (control,
n = 6, stress, n = 6) was subjected to 60 s of forced swim
at 11:00 h, after which the animals were transferred to a
heated holding cage for 10 min. Afterward, the animals were
transported to a separate room (time used approximately 10 s),
quickly anesthetized with isoflurane (time used approximately
5 s) and immediately sacrificed via decapitation under deep
anesthesia to collect blood. Animals were not exposed to
other decapitated animals before deep anesthesia. Another set
of rats (control, n = 6, stress, n = 6) was not disturbed
and sacrificed at 11:11 h under deep anesthesia. The forced
swim consisted of a plastic beaker (25 cm in diameter,
46 cm deep) containing 30 cm of water (19 ± 1◦C). Blood
(1 mL) was collected in heparinized microcapillary tubes
and centrifuged (Model # MiniSpin Plus; Eppendorf AG,
Hamburg, Germany) at 10,000 rpm for 10 min to obtain
plasma and then stored at −70◦C. Total corticosterone was
determined by an Enzyme Immunoassy kit (Corticosterone
BioAssayTM, Catalog. # C7903-30) purchased fromUS Biological
(Swampscott, MA, USA). Optical density values were measured
at 450 nm using a micro-plate reader (Tecan GENiosTM, Tecan
Group Ltd., Switzerland). Samples were diluted 1:10 and then
processed in duplicate and averaged final values were represented
as ng/mL.
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Locomotor Activity
Open Field Test
Locomotor activity was evaluated in the open field test. All
animals were naive to the test situations. The behavioral test
was carried out from 10:00 h to 14:00 h. in the test room. The
activity of each rat was recorded by IP cameras fixed above the
behavioral apparatus and connected to a computer in another
room. Videos were acquired by Nuuo software (Nuuo, Taipei,
Taiwan). Behavioral tests were conducted in a soundproof and
temperature-controlled (21± 1◦C) room. Each rat was placed in
the center of a black Plexiglass cage (70 cm × 70 cm × 40 cm)
for 5 min. The background noise level in the open field was
40 dB SPL (Precision sound level meter, Model # 1100, Quest
Technologies, Oconomowoc, WI, USA) and the arena was
illuminated to 300 lux (measured by a digital lux meter, Model
# LX-1010B, Weafo Instrument Co., Shanghai, China). Total
distance traveled was analyzed from video recordings using
ANY-maze video tracking system (Stoelting Co., Wood Dale, IL,
USA). All mazes were wiped thoroughly clean with a 5% ethanol
solution after each trial. In all experiments, animals from control
and stress experimental groups were evaluated at the same time.
EXPERIMENT 3
The Effects of Reboxetine on Auditory
Attention
Trained rats were subjected to 50 trials of 2-ACT 1 day before
and after the restraint-stress protocol (Scheme 1B). To analyze
the effects of reboxetine on the behavioral performance of
chronically stressed rats in the auditory attention task, a DS was
measured by subtracting the number of correct trials determined
before chronic stress (DS-CT) from the number of correct trials
obtained in the 50 trials after of the chronic stress period. Positive
values for the DS-CT were associated with an increase in correct
trials after the chronic stress period compared to correct trials
before restraint stress. The number of correct trials was measured
using the Packwin software.
EXPERIMENT 4
The Effects of Reboxetine Effects on NE
Content in the Auditory Cortex
After completion of the restraint-stress protocol each rat
treated with vehicle or reboxetine was decapitated under deep
anesthesia with isoflurane. NE content in the auditory cortex was
determined as shown in the description of Experiment 1.
Statistical Analysis
Contents of Monoamines and Metabolites in the
Auditory Cortex
NE concentration in A1 was analyzed using the non-parametric
Mann-Whitney U test. The results shown in Figures 1B–D were
analyzed by a two-way ANOVA. The independent variables were
experimental groups (control and stress) and neurotransmitter
and metabolite contents (5-HT, 5-HIAA, DA, and dopac) in
Figures 1B,C, and the ratio (5-HIIAA/5-HT and dopac/DA) in
Figure 1D. The dependent variables were pg/mg of tissue and
the ratio.
Effects of Reboxetine on Body Weight Gain, Open
Field Test and NE Content
Results were analyzed by a two-way ANOVA. The independent
variables were treatments (vehicle and reboxetine) and stress
(control and stress). The dependent variables were body weight
(body weight gain), total distance traveled (locomotor activity),
and pg/mg of tissue (NE content).
Corticosterone Levels
Corticosterone levels were analyzed by a 3× 2 factorial ANOVA.
The dependent variable was serum corticosterone levels and the
independent variables were restraint stress (control and stress),
treatments (vehicle and reboxetine), and acute stress (without
stimulation and acute swim).
Auditory Attention
The performance of the animals in the 50 trials were analyzed
by a two-way repeated-measure ANOVA (DS [groups (vehicle,
reboxetine)× trials (1–50)]).
Bonferroni post hoc test was used for all experiments for
multiple comparisons.
Data are represented by mean ± SEM. A probability level of
0.05 or less was accepted as significant. The asterisk (∗) indicates
significant differences relative to control animals.
RESULTS
Experiment 1
Effects of Chronic Stress on Monoamine Contents in
the Auditory Cortex
Chronically stressed rats had lower levels of NE in the auditory
cortex than did control animals (p < 0.01; Figure 1A).
As shown in Figures 1B–D a two-way-ANOVA revealed
that restraint stress did not affect 5-HT and 5-HIAA
concentrations (F(1,10) = 0.0013, p = 0.9718), DA and dopac
concentrations (F(1,10) = 2.194, p = 0.1693), and the ratios of
5-HIAA/5-HT and dopac/DA (F(1,10) = 0.3706, p = 0.5562).
In both control and chronically stressed rats, the 5-HIAA
concentrations were significantly higher than 5-HT levels
(F(1,10) = 37.63, p < 0.001; Figure 1B), while the 5-HIAA/5-HT
ratio was higher than the dopac/DA ratio (F(1,10) = 62.55,
p< 0.0001; Figure 1D).
Experiment 2
Stress Markers and Locomotor Activity
To determine whether our chronic stress protocol was effective
in triggering stress response, we measured locomotor activity
and stress markers, including the corticosterone level and body
weight gain. There was a significant effect of the treatment-stress
interaction on body weight gain (F(1,16) = 6.803, p < 0.05). The
post hoc test showed that chronically stressed rats treated with
vehicle had significantly lower body weight gain than control
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FIGURE 2 | Stress levels after 21 days of restraint stress paradigm.
(A) Chronic stress decreased body weight gain, while reboxetine prevented
this effect. (B) After acute swim, serum corticosterone levels were significantly
higher in chronically stressed rats treated with vehicle than in control animals
(black bars), while reboxetine prevented this effect (black bars). (C) Reboxetine
did not affect the locomotor activity of animals in the experimental groups.
∗∗p < 0.01,∗∗∗p < 0.001.
rats (stress: 232.0 ± 5.6 g, control: 284.2 ± 6.4 g; p < 0.001;
Figure 2A).
Figure 2B shows the level of circulating corticosterone in rats
subjected to a 60 s forced swim and in animals that were not
disturbed. Following acute swimming, both stress and treatment
altered corticosterone levels (F(3,20) = 4.644, p < 0.05). There
was a significant effect of the treatment-stress interaction on
corticosterone levels (F(3,20) = 14.26, p < 0.001; Figure 2B).
The post hoc test showed that vehicle-treated controls and
chronically stressed rats that were exposed to acute swim had
higher corticosterone levels than those were left undisturbed
(p < 0.01). Following acute swimming, animals from the stress
group had significantly higher corticosterone levels than did
control rats (p < 0.01). Control rats treated with reboxetine
that were subjected to acute swimming had lower levels of
corticosterone than control rats treated with vehicle (p < 0.05;
Figure 2B). In addition, chronically stressed rats treated with
reboxetine that were subjected to acute swimming had lower
levels of corticosterone than chronically stressed rats treated with
vehicle (p < 0.001; Figure 2B). There was no difference between
control and chronically stressed rats treated with reboxetine after
acute swimming (p> 0.05; Figure 2B).
Neither restraint stress nor reboxetine affected locomotor
activity. There was no main effect of restraint stress
(F(1,16) = 2.661, p = 0.1224) or reboxetine (F(1,10) = 0.090,
p = 0.7682) on the total distance traveled in the open field test
(Figure 2C).
Experiment 3
Effects of Reboxetine on Auditory Attention
The aim of this experiment was to evaluate the effect of the
reboxetine on the auditory attention behavior of control and
chronically stressed rats that were trained in the attentional
task, an auditory frequency discrimination task used to study
attention in rats (Figure 3). Reboxetine did not affect the
DS-CT of control animals in the first 40 trials of the 2-ACT
(Figure 3A). However, after the 40th trial, the DS-CT of
reboxetine-treated rats was higher than that of vehicle-treated
control rats (Figure 3A). There was a significant interaction
between treatment and trial (F(9,162) = 6.214, p < 0.001), while
the effect of treatment was significantly altered (F(9,18) = 5.189,
p < 0.05). The DS-CT of the chronically stressed rats treated
with reboxetine was higher than that of vehicle-treated rats
in the trial 20 of 2-ACT (Figure 3B). Interactions between
treatment and trial, and the effect of treatment increased
significantly (Interaction: F(9,162) = 4.678, p< 0.001); (Treatment:
F(9,18) = 165.3, p < 0.001; Figure 3B). These results demonstrate
that reboxetine improved the behavioral performance of
chronically stressed rats after 20th trial during the auditory
attention task.
Experiment 4
NE Concentration in the Auditory Cortex of Rats
Treated with Reboxetine
Chronically stressed rats treated with vehicle had lower levels of
NE in the auditory cortex than did control animals (p < 0.05;
Figure 4). Reboxetine prevented this effect, as chronically
stressed rats that were treated with reboxetine had higher
levels of NE than did chronically stressed animals treated with
vehicle (p < 0.01; Figure 4). Interactions between treatment and
chronic stress, and the effect of treatment increased significantly
(Interaction: F(1,20) = 6.498, p< 0.05); (Treatment: F(1,20) = 4.482,
p< 0.05; Figure 4).
DISCUSSION
In this study we found that chronic stress specifically decreased
NE concentrations in A1, which could be explained in part by
the relationship between the HPA axis and LC-NE system. It is
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FIGURE 3 | Influence of reboxetine on the auditory attention of chronically stressed rats. The difference score of correct trials (DS-CTs) of control (A) and
chronically stressed rats treated with reboxetine (B) were significantly higher than those of vehicle-treated rats. ∗∗p < 0.01,∗∗∗p < 0.001.
FIGURE 4 | Effect of reboxetine on NE levels in primary auditory cortex
(A1). Reboxetine increased NE in A1 of chronically stressed rats. The asterisk
(∗) indicates significant difference relative to control animals. ∗∗p < 0.01.
possible that in our experiments chronic stress had decreased
LC activity and NE release in the brain. This idea is supported
by the study of Isingrini et al. (2016), who found that mice
exposed to repeated social defeat stress, a chronic stress protocol,
have lower LC activity and decreases NE levels in the ventral
tegmental area (VTA) than compared to unstressed mice. It
was also interesting that optogenetic stimulation of LC-NE
fibers in the VTA reversed the stress phenotype (Isingrini
et al., 2016). In this sense, the study of Pacák et al. (1993),
shows that repeated immobilization stress decreases extracellular
levels of NE and 3-Methoxy-4-hydroxyphenylglycol (MHPG, the
main NE metabolite) in the central nucleus of the amygdala,
suggesting that chronic stress decreases noradrenergic turnover
but not the synthesis of NE in this brain area. The study of
Sakaguchi and Nakamura (1990), demonstrates that chronic
restraint stress decreases LC neuronal activity. Taken together
these evidences suggest that there is a lower activity of the
LC-NE system in chronically stressed rats than in control
animals.
Having demonstrated that chronic stress decreases NE levels
in A1, we determined if reboxetine affects auditory attention
in chronically stressed rats. Firstly, we determined if the
applied chronic stress procedure was effective in triggering stress
responses in the animals treated with vehicle or reboxetine. The
rats subjected to restraint stress and treated with vehicle had
lower body weight gain than did controls injected with vehicle
(Figure 2A). This alteration has been generated by chronic stress
in different animal models and can be explained by increased
glutamatergic activity in the brain, which induces chronic stress
in the limbic system. One effect of this neurophysiological
alteration is increased energy demand provided by lipid
catabolism, which in turn results in lower weight gain, as
can be observed in Figure 2A. This correlates with higher
plasma corticosterone concentrations in chronically stressed
rats than in control rats when they were exposed to an acute
stressor in the form of forced swimming (Figure 2B). This
result suggests that rats exposed to repeated restraint stress
and that were injected with vehicle had a more exacerbated
response of the HPA axis to a new acute stressor than the
control rats treated with vehicle. Interestingly, the treatment with
reboxetine had an anti-stress effect on the animals, preventing
the decrease in weight gain and the increase in corticosterone
levels. These results, which are comparable to those of earlier
studies, show that the chronic stress protocol was effective with
the vehicle-treated rats (Tafet and Bernardini, 2003; Ferraz et al.,
2011).
Having established that our chronic stress protocol was
effective, we evaluated the effects of reboxetine on auditory
attention and NE concentrations in A1. An unexpected result
was that vehicle-treated control rats and vehicle-treated stressed
rats (restraint) had similar performances in the attentional
task (Figure 3). This result suggests that repeated injections
with vehicle were also stressful for control animals and
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deteriorated their auditory attention, although vehicle-treated
rats exposed to restraint stress had lower body weight and
higher corticosterone levels than vehicle-treated control rats
(Figures 2A,B). Figure 2B shows that vehicle-injected control
rats exposed to acute swimming had a higher, but not statistically
significant, increase in the corticosterone levels than those who
were left undisturbed (acute swimming: 250.3 ± 12.6 ng/ml;
unstimulated: 160.5 ± 20.2 ng/ml). If we compare this result
with the ones in our previous article, in relation to the effect
of acute swim on corticosterone plasma levels of control rats,
never injected with vehicle, control rats exposed to acute
swim did not show significant higher corticosterone levels
compared to unstimulated rats (acute swim: 285.1 ± 19.9 ng/ml;
unstimulated: 130.6 ± 17.1 ng/ml; Pérez et al., 2013). It is
possible that injections with vehicle had been stressful for the
rats at the beginning of daily injections, but after 21 days
their HPA axis did adapt to vehicle injections. To support,
10 days of vehicle injection increases plasma corticosterone
levels in rats (Mitra and Sapolsky, 2008) and 3 weeks of
vehicle injections decreases intersections of apical dendrites
of pyramidal neurons located in the medial prefrontal cortex
(mPFC; Wellman, 2001), a brain area that regulated attention
in rodents (Holmes and Wellman, 2009). These evidences
suggest that the mPFC is more sensitive to the stressful
effects induced by vehicle injections than HPA axis and the
long-term effects on mPFC last until 21 days of injections.
In this regard, it has been shown that chronic mild stress
induces dendritic atrophy and decreases synaptic transmission
in the mPFC (Brown et al., 2005; Negrón-Oyarzo et al.,
2015). Therefore, in our experiments, repeated injections with
vehicle may have been stressful for control rats and may have
deteriorated their mPFC, impairing auditory attention as shown
in Figure 3A.
On the other hand, rats that were exposed to vehicle injections
and subjected to repeated restraint stress had significantly higher
corticosterone levels than rats that were not disturbed. This
result suggests that repeated restraint stress was more stressful
for the rats than daily injections and the HPA axis of restraint-
treated rats did not adapt to restraint and exacerbated their
HPA axis response to a new stressor. In this context of chronic
stress, we have reported that A1 shows dendritic atrophy and
decreases of GABAergic efficacy, a brain area that also regulates
auditory attention (Bose et al., 2010; Pérez et al., 2013). Therefore,
it is possible that in our experiments vehicle injections have
been less stressful than restraint, and the effects of injections
on auditory attention have been linked to the mPFC and
other neurotransmitter system (e.g., cholinergic system), because
reboxetine treatment improved attention only in the last five
trials of attentional task (Figure 3A), while repeated restraint
was a strong stressor for the rats and more related to lower
levels of NE in A1. These different levels of chronic stress
should have different consequences in brain circuits, e.g., a more
severe chronic stress could affect a longer extension of altered
brain circuits (A1, subcortical nuclei and mPFC), while lower
levels of chronic stress could affect a more reduced brain area
(mPFC). Consequently, we propose, that reboxetine improved
earlier auditory attention in animals exposed to stronger chronic
stress (restrain) than in those exposed to vehicle injections
(Figure 3B).
An alternative hypothesis is that the observed effects along
trials in vehicle-treated animals were due to sustained attention.
It is known that NE brain levels are important for maintaining
sustained attention in time, and it has been shown that
low dose of nortryptiline (NE reuptake blocker) can improve
the performance of rats in an auditory sustained attention
tasks (Roychowdhury et al., 2012). In this line, the additional
effect of repeated restraint stress could be unmasked by
reboxetine (Figure 3), which might diminish the impairment in
performance produced by sustained attention. In addition, the
effect of restraint-induced chronic stress on auditory attention
depended more on NE levels in the brain than on injections-
induced chronic stress. In this regard, restraint and injections
can induce chronic stress in rats but both appear to be different
stressors for the brain. Figure 4 shows that restraint-induced
chronic stress decreased the NE levels in A1 compared to control
rats that were injected with vehicle, while at behavioral level both
animal groups had a similar performance in the attentional task
(Figure 3).
The effects of reboxetine did not correlate with alterations
in locomotor activity because reboxetine and restraint stress
did not affect the distance traveled in the open field task
(Figure 1B), demonstrating that reboxetine specifically affects
auditory attention.
An interesting fact was that the treatment with reboxetine had
a different effect on each of the control and stress experimental
groups, not only at a behavioral level, but also on the NE
concentration in A1. In rats that were exposed to repeated
restraint stress, vehicle- and reboxetine-treated stressed rats
showed similar levels of attention in the first 20 trials of
the 2-ACT test, after which reboxetine-treated rats had higher
attention levels and NE concentration in A1 than those vehicle-
treated rats (Figures 3B, 4), indicating that NE levels were
necessary to maintain the auditory attention of the animals over
time during the 50 2-ACT trials. On the other hand, reboxetine
treatment improved auditory attention of vehicle-treated control
rats, but only in the last five trials of 2-ACT, while NE levels in
A1were similar to those of control animals treated with vehicle or
reboxetine (Figure 4). If injections would have masked the effect
induced by restraint, then reboxetine effects on attention would
have been similar in control and restrained rats. However, results
from Figures 3, 4 suggest that the effects induced by restraint on
attention were more related with NE levels in the brain, while the
effects related to the stress-induced by daily injections possibly
were more related to changes in adrenoreceptors’ expression at
neocortex.
With the results obtained in this research we cannot explain
how NE affected in particular the auditory attention, so
that further experiments are necessary. Despite this, we can
speculate a possible mechanism and suggest it in this discussion
(Scheme 2). It has been shown that an inhibition/excitation
balance in A1 regulates the rat’s performance in the auditory
discrimination task 2-ACT (Buzsaki and Chrobak, 1995; Cobb
et al., 1995; Wehr and Zador, 2005; Tan and Wehr, 2009;
Znamenskiy and Zador, 2013; Xiong et al., 2015). In this regard,
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SCHEME 2 | Possible cellular mechanisms underlying the effects of
chronic stress and reboxetine on auditory attention in rats. Chronic
stress reduces the activity of locus coeruleus and norepinephrine system
(LC-NE), as a result, NE content decreases in neocortical areas which
modulate attention, e.g., the primary auditory cortex (A1) and the medial
prefrontal cortex (mPFC). In this context, lower levels of NE and/or changes in
the expression of α and β adrenoreceptors (α, β-AR) located at interneurons
could affect GABAergic activity which is crucial to generate brain oscillations in
the neocortex, which in turn impairs auditory attention. On the other hand,
reboxetine treatment improves these alterations.
chronic stress induces both atrophy of the basilar dendrites of
pyramidal neurons (Bose et al., 2010) and decreases GABAergic
synaptic efficacy in A1 (Pérez et al., 2013), which in turn,
could modify the threshold of synaptic plasticity and induce an
imbalance between the excitatory and inhibitory systems. As a
result, the sustained auditory attention of the chronically stressed
rats decreased than control rats in the auditory task (Pérez et al.,
2013).
Interneurons exert a strong control over balance and
synchronization of the brain circuit (Buzsaki and Chrobak,
1995). Therefore, modulation of GABAergic synaptic efficacy in
A1 could be a main regulatory element for auditory attention.
In our experiments, the effects of NE on auditory attention
can be understood by considering how it modulates GABAergic
neurotransmission in A1. It has been shown that NE regulates
GABAergic activity by adrenoreceptors located in neurons
containing the GABAergic marker parvalbumin (PV-positive
neurons; Salgado et al., 2011a,b). Thus, chronic stress induced
by repeated injections or restraint stress could up-regulate the
expression of α1 adrenoreceptors in PV-positive neurons and as
a result GABAergic activity decrease in A1 (Salgado et al., 2011a).
In this regard, PV-positive neurons are crucial to generate some
brain oscillations that modulate attention, for example, alpha
oscillations in the A1 (Lakatos et al., 2016), selectively increase
perisomatic inhibition. On the other hand, reboxetine could have
increased the expression of the β and/or α2 adrenoreceptors
in the PV-positive neurons. A speculative explanation is that
NE could have increased GABAergic transmission in chronically
stressed rats (Sessler et al., 1995; Salgado et al., 2011b, 2012;
Brown et al., 2012), improving their attention in the last trials
of the auditory task, as shown in Figure 3A.
On the other hand, it is possible that the effects of chronic
stress and reboxetine on auditory attention could be in part
induced indirectly. For example, the mPFC plays a key role
in attention and NE modulates their neuronal activity (Dalley
et al., 2004; Bondi et al., 2010). Therefore, in our experiments
the effects of chronic stress and reboxetine on auditory attention
could be generated by the effects of both, chronic stress and
reboxetine, directly on mPFC. In addition, the medial geniculate
nucleus (MGN, auditory thalamus) is also target of NE and
MGN modulates the activity of A1 (Pannese, 2007; Tully et al.,
2007) and thereby chronic stress and reboxetine also can regulate
the MGN activity, which in turn could affect the auditory
attention. In this regard, it is possible that chronic stress
influences attention via an additional mechanism to the NE
system. The auditory pathway and mPFC are strongly regulated
by cholinergic system to support sustained attention (Young
et al., 2004; Schofield et al., 2011; Roychowdhury et al., 2012;
Poorthuis and Mansvelder, 2013; Bloem et al., 2014). It has
been reported that A1, MGN, and mPFC receive cholinergic
innervation from the basal forebrain and acetylcholinemodulates
the neuronal activity of these brain areas during attention
(Passetti et al., 2000; Kamke et al., 2005; Schofield et al., 2011;
Bloem et al., 2014). Moreover, behavioral studies in mice suggest
that cholinergic nicotine activation is relevant for maintaining
sustained attention during 5-choice serial reaction time task
(Young et al., 2004).
Taken together, these evidences suggest that in our
experiments NE could modulate the cholinergic system in
the mPFC and/or A1, which in turn affect sustained auditory
attention. For example, chronic stress could decrease NE and
cholinergic activities, while reboxetine increase both NE and
cholinergic activities improving sustained auditory attention as
shown in Figure 3B.
In conclusion, our results suggest that chronic stress decrease
the NE concentration in A1. On the other hand, reboxetine
improved auditory attention and increased NE in A1 of
chronically stressed rats. In addition, reboxetine had a strong
anti-stress effect. We propose that NE plays a key role in the
stress-induced inhibition of GABA release in A1 and by this way
affects auditory attention of stressed rats.
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